Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

FDA recall notice · announced January 19, 2022 · Taro Pharmaceuticals U.s.a

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3

Reason for recall

Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria

Notes

Distribution: Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
Lot/code information: Lot# AC13786, exp. date DEC 2022
Quantity: 96 tubes
Status: Terminated
Products in this recall event:
- Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532 (D-0375-2022)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.